12 - 14 November 2019 | Barcelona
Strategy, advocacy and partnering for the orphan drug industry
500+ Attendees | 275+ Companies | 80% Decision Makers | 200+ Speakers
What is The World Orphan Drug Congress?
World Orphan Drug Congress is Europe's meeting place for the rare disease community. The Conference offers strategic keynote plenaries, themed tracks and dedicated networking sessions, you have the chance to really tailor the event to the needs of your day-to-day role.
Exhibitors have a unique opportunity to put their business products and services in front of potential buyers looking to source the latest technologies in the orphan drugs industry.
Meet and listen to biotech start-ups and investors in our Pitch & Partner track where the most promising companies showcase their orphan drug technology and pipeline.
PARTNEring
It’s not just about the conference sessions, we recognise the importance of networking.
With roundtable discussions, themed networking receptions, networking lunches and our networking app we offer plenty of opportunities to network with your peers and continue conversations in good company.
Conference
The World Orphan Drug Congress brings together the pioneers doing the most innovative work within the industry and across the whole value chain, to share their unique insights with you.
The event looks at bringing together leaders in the field as well as patient groups, to meet, discuss and progress the industry further.
Exhibition
This is the perfect platform to generate new leads, create brand awareness and launch new products. No other marketing gets you in a room with so many potential customers looking for suppliers.
Sponsorship packages are tailored to meet your specific marketing goals. And, the exhibition floor does sell out, so don’t delay.
Enjoy discussions on:
Cell & Gene Therapies
Genetic Testing
Gene Editing
Partnering & Investment
Global Market Access
Expanded Access Programs
Real World Evidence
Global Patient Advocacy
Value Based Pricing & Reimbursement
Epidemiology & Forecasting
Orphan Drugs Policy
Gene Therapy Development
Together with:
Supported by:
Working with:
2019 Key Speakers
Advisory Board
Wills Hughes-Wilson
Head of Patient Access & Commercial Planning
Mereo Biopharma
Professor Michael Linden
Former VP Gene Therapy & Head, GMI
Pfizer
Yann Le Cam
Chief Executive Officer
EURORDIS
Dr Ségolène Aymé
Founder of Orphanet, Emeritus Research Director
INSERM
Dr Bruno Sepodes
Chair of COMP
EMA
Sheela Upadhyaya
Assoc. Director Highly Specialised Technologies
National Institute For Health and Care Excellence
Alastair Kent
Former Director
Genetic Alliance UK
Dr Carlo Incerti
SVP, Head of Global Medical Affairs, CMO
Genzyme, A Sanofi Company
Dr Mathew Pletcher
Head of Rare Disease Discovery
Roche
M Ken Kengatharan
Managing Partner, Atheneos Ventures and CEO
Auxesia Orion
Birgitte Volck
President Research & Development
AVROBIO
Dr Pedro Franco
Former Scientific Administrator
EMA
Rick Thompson
CEO
Findacure
Dr Alexander Natz
Secretary General
EUCOPE
Anna Bucsics
Project Advisor
MoCA
Josie Godfrey
Former Associate Director
NICE
Dr Diego Ardigo
Chair, IRDiRC Therapies Scientific Committee & R&D Rare Diseases Unit Head at Chiesi Group
Steve Groft
Senior Advisor to Director
National Center for Advancing Translational Sciences (NCATS), NIH
Durhane Wong-Rieger
Chair of RDI and CEO, CORD
Dr Josep Torrent-Farnell
Head of the medicine division
CatSalut
"It is an important meeting that sheds light on the value patient advocates bring to the development process"
Global Medicines Development Lead - Rare Diseases, Pfizer
2019 Sponsors & Exhibitors
Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Gold Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Silver Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Bronze Sponsor
Network Reception Sponsor
Company Showcase Sponsor
Company Showcase Sponsor
Company Showcase Sponsor
Company Showcase Sponsor
Exhibitor
Other
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Exhibitor
Generate new business
Get your brand, your message and your sales people in front of your customers.
The congress opens doors to fantastic opportunities to form lucrative partnerships and source new ground-breaking solutions.
Join us in Barcelona 12-14 November 2019
Organiser
Follow us on
Sign Up for Event Updates
Get Involved At World Orphan Drug Congress 2019
To Sponsor Or Exhibit
Michael Hodge
michael.hodge@terrapinn.com
t/ +44 20 7092 1091
To Speak
Wing-Yun Cheung
wing-yun.cheung@terrapinn.com
t/ +44 20 7092 1172
To Register
Issa Mauthoor
issa.mauthoor@terrapinn.com
t/ +44 20 7092 1257